Is there a role for an external beam boost in cervical cancer radiotherapy?

Frontiers in Oncology

Volumn 3 JAN, Issue , 2013, Pages

  Sethi, Rajni A ^a   Jozsef, Gabor ^a   Grew, David ^a   Marciscano, Ariel ^a   Pennell, Ryan ^a   Babcock, Melissa ^a   McCarthy, Allison ^a   Curtin, John ^a   Schiff, Peter B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brachytherapy; Cervical cancer; External beam radiotherapy

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PLANNING TARGET VOLUME; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOLOGICAL PARAMETERS; TOMOTHERAPY; UTERINE CERVIX CANCER; VOLUMETRIC MODULATED ARC THERAPY;

EID: 84888285976     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00003     Document Type: Article

References (20)

1. Cengiz, M., Dogan, A., Ozyigit, G., Erturk, E., Yildiz, F., Selek, U., et al. (2012). Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer. Brachytherapy 11, 125-129.
2. Chan, P., Dinniwell, R., Haider, M. A., Cho, Y. B., Jaffray, D., Lockwood, G., et al. (2008). Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: a cinematic-MRI point-of-interest study. Int. J. Radiat. Oncol. Biol. Phys. 70, 1507-1515.
3. Chen, S. W., Liang, J. A., Yang, S. N., Ko, H. L., and Lin, F. J. (2003). The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiother. Oncol. 67, 69-76.
4. Clark, B. G., Souhami, L., Roman, T. N., Evans, M. D., and Pla, C. (1994). Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis. Int. J. Radiat. Oncol. Biol. Phys. 28, 1243-1250.
5. Eifel, P. J., Winter, K., Morris, M., Levenback, C., Grigsby, P. W., Cooper, J., et al. (2004). Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J. Clin. Oncol. 22, 872-880.
6. Fokdal, L., Tanderup, K., Nielsen, S. K., Christensen, H. K., Røhl, L., Pedersen, E. M., et al. (2011). Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept. Radiother. Oncol. 100, 473-479.
7. Haas, J. A., Witten, M. R., Clancey, O., Episcopia, K., Accordino, D., and Chalas, E. (2012). Cyperknife boost for patients with cervical cancer unable to undergo brachytherapy. Front. Oncol. 2:25. doi: 10.3389/fonc.2012.00025
8. Hall, E. J., and Wuu, C. S. (2003). Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int. J. Radiat. Oncol. Biol. Phys. 56, 83-88.
9. Hsieh, C. H., Wei, M. C., Hsu, Y. P., Chong, N. S., Chen, Y. J., Hsiao, S. M., et al. (2010). Should helical tomotherapy replace brachytherapy for cervical cancer? Case report. BMC Cancer 10:637. doi: 10.1186/1471-2407-10-637
10. International Commission on Radiation Units and Measurements. (1985). Dose and Volume Specification for Reporting Intracavitary Therapy in Gynecology, Vol. 38, Bethesda: International Commission on Radiation Units and Measurements.
11. Lanciano, R. M., Pajak, T. F., Martz, K., and Hanks, G. E. (1993). The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J. Radiat. Oncol. Biol. Phys. 25, 391-397.
12. Lim, K., Small, W. Jr., Portelance, L., Creutzberg, C., Jürgenliemk-Schulz, I. M., Mundt, A., et al. (2011). Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int. J. Radiat. Oncol. Biol. Phys. 79, 348-355.
13. Pearcey, R., Brundage, M., Drouin, P., Jeffrey, J., Johnston, D., Lukka, H., et al. (2002). Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J. Clin. Oncol. 20, 966-972.
14. Petereit, D. G., and Pearcey, R. (1999). Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? Int. J. Radiat. Oncol. Biol. Phys. 43, 359-366.
15. Pötter, R., Georg, P., Dimopoulos, J. C., Grimm, M., Berger, D., Nesvacil, N., et al. (2011). Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother. Oncol. 100, 116-123.
16. Pötter, R., Knocke, T. H., Fellner, C., Baldass, M., Reinthaller, A., and Kucera, H. (2000). Definitive radiotherapy based on HDR brachytherapy with iridium-192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Cancer Radiother. 4, 159-172.
17. Purdy, J. A. (2008). Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques. Health Phys. 95, 666-676.
18. Rose, P. G., Bundy, B. N., Watkins, E. B., Thigpen, J. T., Deppe, G., Maiman, M. A., et al. (1999). Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340, 1144-1153.
19. Wahab, S. H., Malyapa, R. S., Mutic, S., Grigsby, P. W., Deasy, J. O., Miller, T. R., et al. (2004). A treatment planning study comparing HDR and AGIMRT for cervical cancer. Med. Phys. 31, 734-743.
20. Wang, X., Liu, R., Ma, B., Yang, K., Tian, J., Jiang, L., et al. (2010). High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Cochrane Database Syst. Rev. 7, CD007563.